KR920016404A - 신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도 - Google Patents

신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도 Download PDF

Info

Publication number
KR920016404A
KR920016404A KR1019920000940A KR920000940A KR920016404A KR 920016404 A KR920016404 A KR 920016404A KR 1019920000940 A KR1019920000940 A KR 1019920000940A KR 920000940 A KR920000940 A KR 920000940A KR 920016404 A KR920016404 A KR 920016404A
Authority
KR
South Korea
Prior art keywords
salt
rubidium
cesium
dichloroanilino
water
Prior art date
Application number
KR1019920000940A
Other languages
English (en)
Other versions
KR100203459B1 (ko
Inventor
그라페 잉고마르
쉬카네데르 헬무트
피터 묄스토르프 요한
베르긴 하르투무트
아렌스 쿠르트-헨닝
Original Assignee
제이. 에이취. 아렌스, 알.포츠만
호이만 파마 게엠 바하 운트 콤파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이. 에이취. 아렌스, 알.포츠만, 호이만 파마 게엠 바하 운트 콤파니 filed Critical 제이. 에이취. 아렌스, 알.포츠만
Publication of KR920016404A publication Critical patent/KR920016404A/ko
Application granted granted Critical
Publication of KR100203459B1 publication Critical patent/KR100203459B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/56Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position
    • C07C229/58Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in ortho-position having the nitrogen atom of at least one of the amino groups further bound to a carbon atom of a six-membered aromatic ring, e.g. N-phenyl-anthranilic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

내용 없음

Description

신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 다음 일반식(Ⅰ)의 2-(2,6-디클로아닐리드)-페닐아세트산 염.
    상기식중, Me는 루비듐 또는 세슘 원자이다.
  2. 제1항에 있어서, 일반식(Ⅰ)의 Me+가 루비듐 원자임을 특징으로 하는 염.
  3. 제1항에 있어서, 일반식(Ⅰ)의 Me+가 세슘 원자임을 특징으로 하는 염.
  4. 제1항 내지 3항에 있어서, 2-(2,6-디클로로아닐리노)-페닐아세트산 또는 그의 나트륨 염을 수용성 알코올 용액 또는 수용성 유기 이상계 용액중에서 적당한 루비듐 또는 세슘염과 반응시킴을 특징으로 하는 염의 제조방법.
  5. 제4항에 있어서, 사용된 루비듐 또는 세슘 염이 클로라이드, 브로마이드,설페이트 또는 카보네이트임을 특징으로하는 제조방법.
  6. 활성성분으로서, 제1항 내지 3항중 어느 한항의 염과 생리적으로 적용 가능한 국소적용에 적합한 유기용매를 함유하고, 기타 생리적으로 적용가능한 보조 물질을 함유함을 특징으로 하는 약학적 제제.
  7. 제6항에 있어서, 물과 혼합물로서, 국소 적용에 적합한 유기용매를 함유함을 특징으로 하는 약학적 제제.
  8. 제6항 또는 7항에 있어서, 침투성을 증가시키는 화합물을 또한 함유함을 특징으로 하는 약학적 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920000940A 1991-02-07 1992-01-23 2-(2,6-디클로로아닐리노)-페닐아세트산염, 그 제조방법 및 약학적 제제 KR100203459B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91101674A EP0498011B1 (de) 1991-02-07 1991-02-07 Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen
EP91101674.9 1991-02-07

Publications (2)

Publication Number Publication Date
KR920016404A true KR920016404A (ko) 1992-09-24
KR100203459B1 KR100203459B1 (ko) 1999-06-15

Family

ID=8206378

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920000940A KR100203459B1 (ko) 1991-02-07 1992-01-23 2-(2,6-디클로로아닐리노)-페닐아세트산염, 그 제조방법 및 약학적 제제

Country Status (17)

Country Link
US (1) US5254583A (ko)
EP (1) EP0498011B1 (ko)
JP (1) JP3188741B2 (ko)
KR (1) KR100203459B1 (ko)
AT (1) ATE121724T1 (ko)
AU (1) AU640299B2 (ko)
CA (1) CA2059783C (ko)
DE (1) DE59105323D1 (ko)
DK (1) DK0498011T3 (ko)
ES (1) ES2072462T3 (ko)
GR (1) GR3015937T3 (ko)
HU (2) HUT62853A (ko)
IE (1) IE67183B1 (ko)
IL (1) IL100637A (ko)
NZ (1) NZ241455A (ko)
PT (1) PT100098B (ko)
ZA (1) ZA92288B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20080038376A1 (en) * 2003-08-28 2008-02-14 Pharmaionx, Inc. Anti-cancer composition and method for using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558690A (en) * 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
CH655656B (ko) * 1982-10-07 1986-05-15
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
EP0380712B1 (de) * 1989-01-27 1995-01-04 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
TW225536B (ko) * 1990-08-23 1994-06-21 Ciba Geigy Ag

Also Published As

Publication number Publication date
KR100203459B1 (ko) 1999-06-15
AU1027592A (en) 1992-08-13
ZA92288B (en) 1992-10-28
IL100637A (en) 1996-11-14
HU210536A9 (en) 1995-04-28
US5254583A (en) 1993-10-19
NZ241455A (en) 1993-02-25
DK0498011T3 (da) 1995-07-03
HUT62853A (en) 1993-06-28
EP0498011A1 (de) 1992-08-12
CA2059783C (en) 2003-03-25
AU640299B2 (en) 1993-08-19
HU9200363D0 (en) 1992-04-28
EP0498011B1 (de) 1995-04-26
JPH04312561A (ja) 1992-11-04
JP3188741B2 (ja) 2001-07-16
GR3015937T3 (en) 1995-07-31
CA2059783A1 (en) 1992-08-08
IE920374A1 (en) 1992-08-12
IL100637A0 (en) 1992-09-06
IE67183B1 (en) 1996-03-06
ES2072462T3 (es) 1995-07-16
ATE121724T1 (de) 1995-05-15
PT100098B (pt) 1999-08-31
DE59105323D1 (de) 1995-06-01
PT100098A (pt) 1993-03-31

Similar Documents

Publication Publication Date Title
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
KR900700093A (ko) 수용성 이부프로펜 제제 및 그 제조방법
MD1587B2 (en) Retinoid composition and utilization thereof as therapeutic remedy for topical cutaneous application
KR910014103A (ko) 사람의 손톱 처리용 국소 제제
FI940696A (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
KR910016674A (ko) 신규한 레티노이드
KR920016404A (ko) 신규의 2-(2,6-디클로로아닐리노)-페닐아세트산염 및 그 제조방법과 국소 적용되는 약학적 제제의 용도
DK387884A (da) Benzoesyrederivater, fremgangsmaade til deres fremstilling og deres anvendelse som desinficerende laegemidler eller konserveringsmidler
DK0647129T3 (da) Præparat til topisk anvendelse
KR830009011A (ko) 신규 구아니디노시 클로헥산카복실산 유도체 및 그의 제법
KR940018351A (ko) 노나테트라에노산 유도체
KR850003710A (ko) n-프로판올 아민 에테르 유도체의 제조방법
DK401683A (da) Substituerede benzensulfonsyreestere, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
SE7903200L (sv) Farmaceutiskt, serskilt diuretiskt verksamt preparat for parenteral administration
KR840006767A (ko) 항진균성 겔 조성물
GB1296133A (ko)
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR840006810A (ko) 세팔로스포린 에스테르의 제조방법
KR840001178A (ko) N-메틸-d-글루카민염의 제조
KR850000405A (ko) 항진균제의 제조방법
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
JPS6463552A (en) 4-biphenylylacetic acid ester-cyclodextrin inclusion compound
KR880009026A (ko) 리파마이신 유도체 염
KR900013959A (ko) γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
KR830005094A (ko) 2-(4-이소부틸페닐)-프로피온산 유도체의 제조

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020319

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee